Trian's Peltz seeks a seat on board at Procter & Gamble

Associated Press |

NEW YORK (AP) — Activist investor Nelson Peltz is attempting to secure a seat on the board at Procter & Gamble board member, seeking faster changes at the consumer products company.



Peltz's Trian Fund Management LP, which owns about $3.3 billion worth of shares at Procter & Gamble, said Monday that it's interested in helping Procter & Gamble improve its performance, saying that its financial performance over the last 10 years has been disappointing. The company's sales have declined over the last three years.

Trian said that it's not looking to break up P&G or replace CEO David Taylor or remove other board members.

The Procter & Gamble Co., based in Cincinnati, said in a release that it's maintained an active dialogue with Trian, but that it's sticking with strategy.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Lexaria Bioscience Corp

Lexaria Bioscience Corp is a food sciences company. It has two distinct consumer product brands: ViPova and Lexaria Energy. It uses patent pending technology to infuse hemp oil ingredients within…

Private Markets

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.